Somatic BRCA alterations in breast cancer are associated with distinct biological and clinical patterns according to germline BRCA status
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Foundation for the National Institutes of Health
- Japan Society for the Promotion of Science
This publication has 30 references indexed in Scilit:
- Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor BoardThe Oncologist, 2023
- Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trialGynecologic Oncology, 2021
- A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation StatusOncology and Therapy, 2021
- Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patientsGynecologic Oncology, 2019
- BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patientsBreast Cancer Research and Treatment, 2019
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast CancerNew England Journal of Medicine, 2018
- Mechanisms of PARP inhibitor sensitivity and resistanceDNA Repair, 2018
- Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genesNature Communications, 2017
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationNew England Journal of Medicine, 2017
- Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutationsJournal of Neuro-Oncology, 2017